The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
111-124
Author(s):
Patrick Onyango
Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
147-163
Author(s):
Albert F. Kabore, James B. Johnston and Spencer B. Gibson
Carotenoids and Modulation of Cancer: Molecular Targets
Journal:
Current Pharmacogenomics
Volume:
2
Page:
35-45
Author(s):
Paola Palozza
Subject index to volume 3
Journal:
Current Molecular Medicine
Volume:
4
Page:
69-75
Author(s):
Bentham Science Publishers
A Mechanistic Overview on Male Infertility and Germ Cell Cancers
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
449-469
Author(s):
Pascale Crepieux, Charlotte Lecureuil, Sebastien Marion, Elodie Kara, Vincent Piketty, Nadine Martinat, Florian Guillou, Dominique Royere and Eric Reiter
Gene Therapy for Cardiovascular Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
407-423
Author(s):
Marcin Gruchala, Himadri Roy, Shalini Bhardwaj and Seppo Yla-Herttuala
Prostate Cancer Prevention by Silibinin
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
1-11
Author(s):
Rana P. Singh and Rajesh Agarwal
A Dual Role of Cyclin E in Cell Proliferation and Apotosis May Provide a Target for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
65-75
Author(s):
S. Mazumder, E. L. DuPree and A. Almasan
Genetic Abnormalities in Prostate Cancer
Journal:
Current Genomics
Volume:
5
Page:
67-83
Author(s):
Sanjeev Shukla, Gregory T. MacLennan, Susan R. Marengo, Allen D. Seftel, Martin I. Resnick and Sanjay Gupta
The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
1
Page:
53-74
Author(s):
Patrick Englebienne